1 / 6

ABHI Presentation to RCS

ABHI Presentation to RCS. October 2011. MD Regulatory Reform. AGENDA EU Council Conclusions June 2011 What Needs Improving Industry Recommendation for New Framework. MD Regulatory Reform. EU Council Conclusions Innovation and the role of SME’s

marva
Télécharger la présentation

ABHI Presentation to RCS

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. ABHI Presentation to RCS October 2011

  2. MD Regulatory Reform AGENDA • EU Council Conclusions June 2011 • What Needs Improving • Industry Recommendation for New Framework

  3. MD Regulatory Reform EU Council Conclusions • Innovation and the role of SME’s • Innovation that is safe, effective and timely • Further Development of Post-Marketing Surveillance and Vigilance • Transparency • Tighter Controls over Notified Bodies

  4. MD Regulatory Reform Industry Recommendations • Current system has brought safe and innovative products to patients • Regulation needs to differentiate between devices and pharmaceuticals • Design Controls for Engineering Technologies • Previous successes; Orthopaedics, Stents, Cardiac Catheters

  5. MD Regulatory Reform Improvements (1) • Notified Bodies • Designation and Control • Enhanced Accreditation Procedures • Training and Monitoring • PMS and Vigilance • Criteria for reporting, timelines and coordination • Central Reporting • Coordination between Authorities

  6. MD Regulatory Reform Improvements (2) • Novel Technologies • New structures must not stifle innovation • Design Management • Scientific Support with clear direction • Transparency • Patient and citizen en-powerment • Use of Information Technology • Data basing

More Related